{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:16:48Z","timestamp":1781090208413,"version":"3.54.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.exer.2017.02.015","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T22:50:33Z","timestamp":1488322233000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy"],"prefix":"10.1016","volume":"159","author":[{"given":"Ning","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4482-3319","authenticated-orcid":false,"given":"Yiqiao","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.exer.2017.02.015_bib2","first-page":"549","article-title":"Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase","volume":"9","author":"Al-Shabrawey","year":"2003","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.exer.2017.02.015_bib3","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ctrv.2013.07.007","article-title":"Unraveling galectin-1 as a novel therapeutic target for cancer","volume":"40","author":"Astorgues-Xerri","year":"2014","journal-title":"Cancer Treat. Rev."},{"issue":"10","key":"10.1016\/j.exer.2017.02.015_bib4","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.ophtha.2006.05.064","article-title":"Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy","volume":"113","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.exer.2017.02.015_bib5","doi-asserted-by":"crossref","first-page":"e50860","DOI":"10.1371\/journal.pone.0050860","article-title":"In\u00a0vivo imaging and quantification of carbonic anhydrase IX expression as an endogenous biomarker of tumor hypoxia","volume":"7","author":"Bao","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.exer.2017.02.015_bib6","doi-asserted-by":"crossref","first-page":"137R","DOI":"10.1093\/glycob\/cwl025","article-title":"Galectin-1: a small protein with major functions","volume":"16","author":"Camby","year":"2006","journal-title":"Glycobiology"},{"issue":"3","key":"10.1016\/j.exer.2017.02.015_bib7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/1097-4652(200009)184:3<301::AID-JCP3>3.0.CO;2-H","article-title":"Retinal and choroidal neovascularization","volume":"184","author":"Campochiaro","year":"2000","journal-title":"J.\u00a0Cell Physiol."},{"issue":"7347","key":"10.1016\/j.exer.2017.02.015_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10144","article-title":"Molecular mechanisms and clinical applications of angiogenesis","volume":"473","author":"Carmeliet","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.exer.2017.02.015_bib9","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.exer.2013.12.019","article-title":"N\u00a0-methyl- N -nitrosourea-induced retinal degeneration in mice","volume":"121","author":"Chen","year":"2014","journal-title":"Exp. Eye Res."},{"issue":"11","key":"10.1016\/j.exer.2017.02.015_bib10","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nprot.2009.187","article-title":"Quantification of oxygen-induced retinopathy in the mouse: a model of vessel loss, vessel regrowth and pathological angiogenesis","volume":"4","author":"Connor","year":"2009","journal-title":"Nat. Protoc."},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.cell.2014.01.043","article-title":"Glycosylation-dependent lectin-receptor interactions preserve angiogenesis in anti-VEGF refractory tumors","volume":"156","author":"Croci","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.exer.2017.02.015_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/09553002.2012.683509","article-title":"Tumour microenvironment and radiation response in sarcomas originating from tumourigenic human mesenchymal stem cells","volume":"88","author":"D'Andrea","year":"2012","journal-title":"Int. J. Radiat. Biol."},{"issue":"6","key":"10.1016\/j.exer.2017.02.015_bib13","doi-asserted-by":"crossref","first-page":"e67029","DOI":"10.1371\/journal.pone.0067029","article-title":"VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis","volume":"8","author":"D'Haene","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.exer.2017.02.015_bib14","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1172\/JCI76492","article-title":"Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk","volume":"124","author":"Dejda","year":"2014","journal-title":"J.\u00a0Clin. Invest"},{"issue":"6","key":"10.1016\/j.exer.2017.02.015_bib15","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/ijmm.2015.2371","article-title":"CCN1\/Cyr61-PI3K\/AKT signaling promotes retinal neovascularization in oxygen-induced retinopathy","volume":"36","author":"Di","year":"2015","journal-title":"Int. J. Mol. Med."},{"issue":"16","key":"10.1016\/j.exer.2017.02.015_bib16","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/1078-0432.CCR-09-0095","article-title":"Tumor and host-mediated pathways of resistance and disease progression in response to antiangiogenic therapy","volume":"15","author":"Ebos","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.exer.2017.02.015_bib17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10456-010-9184-y","article-title":"Moderate GSK-3beta inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy","volume":"13","author":"Hoang","year":"2010","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib18","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1124\/pr.56.4.3","article-title":"Vascular endothelial growth factor and angiogenesis","volume":"56","author":"Hoeben","year":"2004","journal-title":"Pharmacol. Rev."},{"issue":"6","key":"10.1016\/j.exer.2017.02.015_bib19","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/CIRCRESAHA.107.167171","article-title":"Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis","volume":"102","author":"Holderfield","year":"2008","journal-title":"Circ. Res."},{"issue":"26","key":"10.1016\/j.exer.2017.02.015_bib20","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1038\/sj.onc.1211029","article-title":"Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells","volume":"27","author":"Hsieh","year":"2008","journal-title":"Oncogene"},{"issue":"3\u20134","key":"10.1016\/j.exer.2017.02.015_bib21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10555-012-9388-2","article-title":"Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment","volume":"31","author":"Ito","year":"2012","journal-title":"Cancer Metastasis Rev."},{"issue":"17","key":"10.1016\/j.exer.2017.02.015_bib22","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"Jain","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.exer.2017.02.015_bib23","doi-asserted-by":"crossref","first-page":"17946","DOI":"10.1038\/srep17946","article-title":"Aflibercept traps Galectin-1, an angiogenic factor associated with diabetic retinopathy","volume":"5","author":"Kanda","year":"2015","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.exer.2017.02.015_bib24","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.4049\/jimmunol.177.8.5727","article-title":"Interaction of vascular endothelial growth factor 165 with neuropilin-1 protects rheumatoid synoviocytes from apoptotic death by regulating Bcl-2 expression and Bax translocation","volume":"177","author":"Kim","year":"2006","journal-title":"J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1586\/17512433.2015.990379","article-title":"Current choice of treatments for neovascular AMD","volume":"8","author":"Lai","year":"2015","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.exer.2017.02.015_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.exer.2016.05.007","article-title":"Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis","volume":"147","author":"Lange","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.exer.2017.02.015_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","article-title":"Ocular neovascularization: an epidemiologic review","volume":"43","author":"Lee","year":"1998","journal-title":"Surv. Ophthalmol."},{"issue":"9","key":"10.1016\/j.exer.2017.02.015_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4331\/wjbc.v2.i9.193","article-title":"Galectin-1-mediated biochemical controls of melanoma and glioma aggressive behavior","volume":"2","author":"Lefranc","year":"2011","journal-title":"World J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib29","doi-asserted-by":"crossref","first-page":"e85824","DOI":"10.1371\/journal.pone.0085824","article-title":"Inhibition of oxygen-induced ischemic retinal neovascularization with adenoviral 15-lipoxygenase-1 gene transfer via up-regulation of PPAR-gamma and down-regulation of VEGFR-2 expression","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.exer.2017.02.015_bib30","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1089\/cbr.2005.20.648","article-title":"Vascular endothelial growth factor in thyroid cancers","volume":"20","author":"Lin","year":"2005","journal-title":"Cancer Biother Radiopharm."},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.11607\/prd.0868","article-title":"The role of hypoxia in the regulation of osteogenesis and angiogenesis coupling in intraoral regenerative procedures: a review of the literature","volume":"33","author":"Mamalis","year":"2013","journal-title":"Int. J. Periodontics Restor. Dent."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib33","doi-asserted-by":"crossref","first-page":"e85031","DOI":"10.1371\/journal.pone.0085031","article-title":"Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy","volume":"9","author":"Michan","year":"2014","journal-title":"PLoS One"},{"issue":"7228","key":"10.1016\/j.exer.2017.02.015_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature07756","article-title":"Small RNAs in transcriptional gene silencing and genome defence","volume":"457","author":"Moazed","year":"2009","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.exer.2017.02.015_bib35","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.yexcr.2005.10.017","article-title":"VEGF-A, cytoskeletal dynamics, and the pathological vascular phenotype","volume":"312","author":"Nagy","year":"2006","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib36","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S1050-1738(01)00140-2","article-title":"The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis","volume":"12","author":"Neufeld","year":"2002","journal-title":"Trends Cardiovasc Med."},{"issue":"7","key":"10.1016\/j.exer.2017.02.015_bib37","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00417-010-1315-z","article-title":"A\u00a0review of clinical trials of anti-VEGF agents for diabetic retinopathy","volume":"248","author":"Nicholson","year":"2010","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"7","key":"10.1016\/j.exer.2017.02.015_bib38","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/sj.bjc.6602493","article-title":"Galectin-1 as a potential cancer target","volume":"92","author":"Rabinovich","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.exer.2017.02.015_bib39","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/bjc.2014.604","article-title":"The tumour hypoxia marker pimonidazole reflects a transcriptional programme associated with aggressive prostate cancer","volume":"112","author":"Ragnum","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1167\/iovs.07-1356","article-title":"Activated NAD(P)H oxidase from supplemental oxygen induces neovascularization independent of VEGF in retinopathy of prematurity model","volume":"49","author":"Saito","year":"2008","journal-title":"Invest Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2017.02.015_bib41","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/978-1-4939-1396-1_19","article-title":"Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods","volume":"1207","author":"Salatino","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"10","key":"10.1016\/j.exer.2017.02.015_bib42","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1523\/JNEUROSCI.22-10-03987.2002","article-title":"Inducible nitric oxide synthase mediates retinal apoptosis in ischemic proliferative retinopathy","volume":"22","author":"Sennlaub","year":"2002","journal-title":"J.\u00a0Neurosci."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib43","first-page":"101","article-title":"Oxygen-induced retinopathy in the mouse","volume":"35","author":"Smith","year":"1994","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"2","key":"10.1016\/j.exer.2017.02.015_bib44","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s13277-015-3942-9","article-title":"Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression","volume":"37","author":"Tang","year":"2016","journal-title":"Tumour Biol."},{"issue":"43","key":"10.1016\/j.exer.2017.02.015_bib45","doi-asserted-by":"crossref","first-page":"15975","DOI":"10.1073\/pnas.0603883103","article-title":"Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy","volume":"103","author":"Thijssen","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.exer.2017.02.015_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ydbio.2004.12.017","article-title":"Attenuation of retinal vascular development and neovascularization during oxygen-induced ischemic retinopathy in Bcl-2-\/- mice","volume":"279","author":"Wang","year":"2005","journal-title":"Dev. Biol."},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib47","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10456-014-9431-8","article-title":"Galectin-1 induces vascular permeability through the neuropilin-1\/vascular endothelial growth factor receptor-1 complex","volume":"17","author":"Wu","year":"2014","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.exer.2017.02.015_bib48","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1167\/iovs.15-17411","article-title":"Vascular normalization by ROCK inhibitor: therapeutic potential of ripasudil (K-115) eye drop in retinal angiogenesis and hypoxia","volume":"57","author":"Yamaguchi","year":"2016","journal-title":"Invest Ophthalmol. Vis. Sci."},{"issue":"8","key":"10.1016\/j.exer.2017.02.015_bib49","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ddr.21282","article-title":"Antiarthritis effect of morin is associated with inhibition of synovial angiogensis","volume":"76","author":"Zeng","year":"2015","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.exer.2017.02.015_bib50","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.2147\/DDDT.S87920","article-title":"Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application","volume":"9","author":"Zhang","year":"2015","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.exer.2017.02.015_bib51","first-page":"492","article-title":"Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation","volume":"17","author":"Zhong","year":"2011","journal-title":"Mol. Vis."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483517301501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483517301501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T01:52:51Z","timestamp":1568857971000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483517301501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":51,"alternative-id":["S0014483517301501"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2017.02.015","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silencing of galectin-1 inhibits retinal neovascularization and ameliorates retinal hypoxia in a murine model of oxygen-induced ischemic retinopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2017.02.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}